フロリダ州におけるメルケル細胞癌の臨床試験
フロリダ州内の拠点で、メルケル細胞癌に関する11件の研究が参加者を募集しています。
フロリダ州内の都市
公式研究テキスト（英語）
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
- Mayo Clinic in Florida, Jacksonville
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07285044Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
- MDR Core Network, Boynton Beach
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/24更新 · NCT06047379Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
- Sylvester Comprehensive Cancer Center - Miami, Miami
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/18更新 · NCT05267626Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer
- UM Sylvester Comprehensive Cancer Center at Aventura, Aventura
- UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables
- UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach
- 他4件
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/31更新 · NCT05896839Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors
- Mayo Clinic in Florida, Jacksonville
被験者募集中第1/2相
16歳以上 · 全性別 · 2026/08/20更新 · NCT05269381A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
- AdventHealth Celebration, Celebration
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/11更新 · NCT05592626Neoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma and Locoregionally Advanced Cutaneous Squamous Cell Carcinoma
- Moffitt Cancer Center, Tampa
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/25更新 · NCT04975152MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors
- Moffitt Cancer Center, Tampa
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/11更新 · NCT05076760Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma
- Mayo Clinic Comprehensive Cancer Center, Jacksonville
- Sylvester Comprehensive Cancer Center, Miami
- Moffitt Cancer Center, Tampa
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/04/17更新 · NCT06947928IFx-Hu2.0 As An Adjunctive Therapy To Pembrolizumab In Advanced Or Metastatic Merkel Cell Carcinoma (MCC)
- H. Lee Moffitt Cancer Center and Research Institute, Tampa
被験者募集中第1相
18歳以上 · 全性別 · 2025/10/15更新 · NCT06940440A Beta-only IL-2 ImmunoTherapY Study
- Boca Raton Regional Hospital, Boca Raton
被験者募集中第1/2相
18歳以上 · 全性別 · 2025/07/09更新 · NCT05086692ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。